YIELD10 BIOSCIENCE, INC. financial data

Location
Woburn, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 14 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 36% % -84%
Debt-to-equity -247% % -292%
Return On Equity 436% %
Return On Assets -296% % -59%
Operating Margin -1679% % 69%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 657,160 shares -89%
Common Stock, Shares, Outstanding 642,497 shares -89%
Common Stock, Value, Issued $6,000 USD -90%
Weighted Average Number of Shares Outstanding, Basic 642,444 shares 169%
Weighted Average Number of Shares Outstanding, Diluted 642,444 shares 169%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $750,000 USD 191%
Costs and Expenses $13,343,000 USD -7.5%
Operating Income (Loss) $12,593,000 USD 11%
Nonoperating Income (Expense) $109,000 USD -348%
Net Income (Loss) Attributable to Parent $12,702,000 USD 11%
Earnings Per Share, Basic 22 USD/shares 67%
Earnings Per Share, Diluted 22 USD/shares 67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $733,000 USD -69%
Assets, Current $1,204,000 USD -60%
Property, Plant and Equipment, Net $432,000 USD -35%
Operating Lease, Right-of-Use Asset $1,297,000 USD -30%
Other Assets, Noncurrent $23,000 USD -66%
Assets $2,968,000 USD -49%
Accounts Payable, Current $2,369,000 USD 407%
Employee-related Liabilities, Current $647,000 USD 134%
Accrued Liabilities, Current $1,828,000 USD 33%
Liabilities, Current $7,669,000 USD 210%
Operating Lease, Liability, Noncurrent $1,087,000 USD -41%
Liabilities $9,206,000 USD 74%
Accumulated Other Comprehensive Income (Loss), Net of Tax $262,000 USD -7.4%
Retained Earnings (Accumulated Deficit) $419,862,000 USD -3.1%
Stockholders' Equity Attributable to Parent $6,238,000 USD -1163%
Liabilities and Equity $2,968,000 USD -49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $903,000 USD 66%
Net Cash Provided by (Used in) Financing Activities $1,211,000 USD 759%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 150,000,000 shares 150%
Common Stock, Shares, Issued 642,497 shares -89%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $745,000 USD -71%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,720,000 USD 11%
Operating Lease, Liability, Current $676,000 USD 7.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $66,000 USD -4.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%